White House Issues Executive Order to Implement Most-Favored-Nation Drug Pricing Policy
On May 12, 2025, the White House issued a wide-reaching Executive Order (“EO“) titled “Delivering Most Favored Nation Prescription Drug Pricing to American Patients” for the stated purpose of ensuring that American patients will have access to the most-favored-nation (“MFN“) price for prescription drugs and biologics.1 This EO came out about one month after the […]
The post New White House Executive Order to Establish “Most-Favored-Nation” Drug Pricing appeared first on Healthcare & Life Sciences Blog.
Read More